Courtesy Story | Defense Threat Reduction Agency's Chemical and Biological Technologies Department | 06.15.2020
Just as a fruit needs time to ripen, so a candidate vaccine needs time to progress to an approval by the U.S. Food and Drug Administration (FDA). On December 19, 2019, the world’s first vaccine for Ebola virus disease, Ervebo, received FDA approval. The development and evaluation of Ervebo spanned several decades, beginning in 1976, and involved multiple organizations, including the Defense......
Story by Adam Lowe | Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND) | 12.20.2019
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical’s (JPM CBRN Medical) involvement with today’s U.S. Food and Drug Administration (FDA)-approval of the world’s first Ebola vaccine contributed to a leap forward in protecting both the warfighter and......
Story by Staff Sgt. Lance Pounds | U.S. Army Southern European Task Force, Africa | 04.07.2016
VICENZA, Italy – Armed Forces of Liberia Chief of Staff, Brig. Gen. Daniel Ziankahn, met with U.S. Army Africa Commanding General, Maj. Gen. Darryl Williams and other USARAF staff to reaffirm the partnership between the two nation’s armies during a command sponsored visit, here, May 4-6, 2016. “The visit helped to solidify our relationship, one that we have been building over the......
Story by Carden Hedelt | Marine Corps Systems Command | 10.23.2014
A little acquisition experience can go a long way. In the White House’s call for ideas to provide personal protective equipment to those caring for Ebola patients in West Africa, that acquisition experience is coming from Scott Paris, a Marine Corps Systems Command employee....
